Results 141 to 150 of about 5,468 (165)

Targeting bile-acid signalling for metabolic diseases

Nature Reviews Drug Discovery, 2008
Charles Thomas, Johan Auwerx, Kristina Schoonjans   +2 more
exaly  

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2015
Brent A Neuschwander-Tetri, Arun J Sanyal, Joel E Lavine   +2 more
exaly  

The sweet spot: defining virus–sialic acid interactions

Nature Reviews Microbiology, 2014
Thilo Stehle, Terence S Dermody
exaly  

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Lancet, The, 2010
Ian Roberts, Jose Caballero, Yashbir Dewan   +2 more
exaly  

The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection

Cell, 2018
Hideki Hara, Koichi Fukase, Mathias Chamaillard   +2 more
exaly  

Mevalonic acid and carotenogenes in carrot extracts

Die Naturwissenschaften, 1961
V. V. Modi, D. K. Patwa
openaire   +1 more source

Modelling strategies for the industrial exploitation of lactic acid bacteria

Nature Reviews Microbiology, 2006
Bas Teusink, Eddy J Smid
exaly  

Prostatic Acid Phosphatase: Where Are We?

Ca-A Cancer Journal for Clinicians, 1978
exaly  

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

Nature Reviews Drug Discovery, 2008
Masato Furuhashi
exaly  

Antimetabolites of Mevalonic Acid¹

Journal of the American Chemical Society, 1959
John Morrow Stewart, D. W. Woolley
openaire   +1 more source